Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT01009580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S